- Home
- SNTI vs SELF Comparison
SNTI vs SELF Comparison
Compare SNTI & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- SELF
- Stock Information
- Founded
- SNTI 2016
- SELF 1983
- Country
- SNTI United States
- SELF United States
- Employees
- SNTI N/A
- SELF N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- SELF Real Estate Investment Trusts
- Sector
- SNTI Health Care
- SELF Real Estate
- Exchange
- SNTI Nasdaq
- SELF Nasdaq
- Market Cap
- SNTI 53.6M
- SELF 56.7M
- IPO Year
- SNTI N/A
- SELF N/A
- Fundamental
- Price
- SNTI $1.91
- SELF $5.00
- Analyst Decision
- SNTI Strong Buy
- SELF
- Analyst Count
- SNTI 3
- SELF 0
- Target Price
- SNTI $9.67
- SELF N/A
- AVG Volume (30 Days)
- SNTI 292.3K
- SELF 27.2K
- Earning Date
- SNTI 11-12-2025
- SELF 11-07-2025
- Dividend Yield
- SNTI N/A
- SELF 5.83%
- EPS Growth
- SNTI N/A
- SELF 9.99
- EPS
- SNTI N/A
- SELF 0.22
- Revenue
- SNTI N/A
- SELF $12,707,884.00
- Revenue This Year
- SNTI N/A
- SELF $2.50
- Revenue Next Year
- SNTI $150.00
- SELF $1.46
- P/E Ratio
- SNTI N/A
- SELF $22.60
- Revenue Growth
- SNTI N/A
- SELF 4.08
- 52 Week Low
- SNTI $1.26
- SELF $4.73
- 52 Week High
- SNTI $16.94
- SELF $5.89
- Technical
- Relative Strength Index (RSI)
- SNTI 49.03
- SELF 50.91
- Support Level
- SNTI $1.92
- SELF $4.91
- Resistance Level
- SNTI $2.29
- SELF $5.05
- Average True Range (ATR)
- SNTI 0.16
- SELF 0.09
- MACD
- SNTI -0.03
- SELF 0.01
- Stochastic Oscillator
- SNTI 0.00
- SELF 84.37
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.